Scarica l'app Stockscreener
0.4441
0.07%
-0.0003
Pre-mercato:
.47
0.0259
+5.83%
Precedente Chiudi:
$0.4444
Aprire:
$0.4518
Volume 24 ore:
12,973
Relative Volume:
0.11
Capitalizzazione di mercato:
$17.79M
Reddito:
$3.81M
Utile/perdita netta:
$-7.29M
Rapporto P/E:
-2.0762
EPS:
-0.2139
Flusso di cassa netto:
$-5.72M
1 W Prestazione:
-2.18%
1M Prestazione:
-8.24%
6M Prestazione:
-50.15%
1 anno Prestazione:
-57.70%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.4384
$0.489
Portata 52W:
$0.3401
$1.60
Dyadic International Inc De Stock (DYAI) Company Profile
Nome
Dyadic International Inc De
Settore
Industria
Telefono
561-743-8333
Indirizzo
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DYAI
Dyadic International Inc De
|
0.4441 | 17.79M | 3.81M | -7.29M | -5.72M | -0.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Ripresa | H.C. Wainwright | Buy |
| 2025-09-08 | Iniziato | Craig Hallum | Buy |
| 2022-07-18 | Downgrade | Dawson James | Buy → Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
Dyadic International Inc De Borsa (DYAI) Ultime notizie
Dyadic International stock faces two Nasdaq compliance tests - AD HOC NEWS
Dyadic International stock faces two Nasdaq compliance tests - AD HOC NEWS
Dyadic International (Nasdaq:DYAI)Stock Analysis - Simply Wall Street
Dyadic International Faces Nasdaq Listing Compliance Challenges - The Globe and Mail
Form 8K Dyadic International Inc For: 25 September By Investing.com - Investing.com Nigeria
Dyadic International Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Dyadic gets Nasdaq notices over $1, $35M rules - Stock Titan
Dyadic International stock rises 2.5 percent as warrants add risk - AD HOC NEWS
Dyadic International stock trades without a fresh market catalyst - AD HOC NEWS
Dyadic International stock edges higher as S-1 registration becomes effective - AD HOC NEWS
DYADIC INTERNATIONAL INC SEC Filing (Sep 21, 2026) - Stock Titan
Emerging Growth Patterns Driving Rapid Expansion in the Protein Hydrolysis Enzymes Market - openPR.com
iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 - Finviz
Dyadic International (Nasdaq: DYAI) Advances Protein Manufacturing Platforms with Global Health Research Support - usatoday.com
Imperium AI Announces Board Discussion Regarding Dyadic Biotechnology Developments - usatoday.com
Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products - StreetInsider
Dyadic International (DYAI) Q2 2026 Earnings Call Transcript - AOL.ca
Amylase Enzyme Cleaner Market Growth to 2035 Driven by Membrane Filtration DemandNews and Statistics - IndexBox
Llamada de resultados del T2 de 2026 de Dyadic International (DYAI): progreso comercial y riesgo de liquidez - TradingKey
Dyadic International Announces New Equity Financing Agreements - TipRanks
Dyadic International (DYAI) Ergebniskonferenz Q2 2026: Kommerzielle Fortschritte und Liquiditätsrisiko - TradingKey
Dyadic International (NASDAQ: DYAI) prices $2.9M stock sale and warrant placement - Stock Titan
Dyadic International Earnings Call: Promise Amid Cash Strain - TipRanks
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire
Dyadic International, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Dyadic raises $2.9 million in registered direct offering - Investing.com
Dyadic International Warns of Going-Concern Risk as Dilution, Nasdaq Uncertainty and Noteholder Dependence Threaten Shareholder Value - TipRanks
Dyadic International Q2 Results: EPS Misses Estimate, Sales Down 0.6% YoY - scanx.trade
Dyadic Announces Second Quarter 2026 Financial Results - GlobeNewswire
Dyadic reports Q2 loss amid commercialization efforts - Investing.com
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas - Yahoo Finance
Dyadic International Inc (DYAI) (Q2 2026) Earnings Call Highlights: Revenue Surges 52% as ... - Yahoo Finance
Earnings To Watch: Dyadic International Inc (DYAI) Q2 2026 -- GF Value Sees 40% Downside - Yahoo Finance
Cellulase Silage Additives Market Growth to 2035 Driven by Asia-Pacific Livestock ExpansionNews and Statistics - IndexBox
Segmentation, Major Trends, and Competitive Overview of the Specialty Enzymes Market - openPR.com
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire
Dyadic signs license deal for precision-fermented dairy proteins - Investing.com
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 - GlobeNewswire
Dyadic Delivers Two Bundibugyo Ebola Antigens for Preclinical Evaluation - Stock Titan
Form 4 Dyadic International Inc For: 25 July By Investing.com - Investing.com South Africa
Form 4 Dyadic International Inc For: 25 July By Investing.com - Investing.com Canada
Francisco trust disposes of $124,957 in Dyadic International stock By Investing.com - Investing.com Canada
Dyadic Regains Nasdaq Compliance, Secures Continued Listing - TipRanks
Dyadic regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Dyadic International, Inc. (DYAI) stock price, news, quote and history - Yahoo Finance Singapore
Dyadic Announces Continued Listing on the Nasdaq Capital Market - GlobeNewswire
Dyadic Announces Continued Listing on the Nasdaq Capital Market - GlobeNewswire
Dyadic regains compliance with Nasdaq listing requirements - Investing.com
Dyadic International Inc De Azioni (DYAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dyadic International Inc De Azioni (DYAI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Francisco Trust under agreemen | 10% Owner |
Jul 24 '26 |
Sale |
1.21 |
2,616 |
3,173 |
3,280,272 |
| Francisco Trust under agreemen | 10% Owner |
Jul 22 '26 |
Sale |
1.33 |
38,016 |
50,481 |
3,337,648 |
| Francisco Trust under agreemen | Greater than 10% holder |
Jul 21 '26 |
Proposed Sale |
1.48 |
364,387 |
539,296 |
0 |
1.64%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):